Our facility is a clinical DNA diagnostic laboratory which combines genetic testing for both inherited disorders and somatic cancers. We work jointly with the Divisions of Genetic and Genomic Medicine and Laboratory and Genomic Medicine of Washington University School of Medicine and the Siteman Cancer Center at Barnes-Jewish Hospital. The laboratory director is Barbara Zehnbauer, PhD FACMG. We are CAP (#19233-01) and CLIA (#26DO438670) accredited and we are listed in the AMP Test Directories and GeneTests.

These web pages contain information about the tests we currently offer:

• Medical Genetics Tests:
  Angelman Syndrome, Beckwith-Wiedemann Syndrome, Cystic Fibrosis, Fragile X Syndrome, Fragile X Tremor-associated Ataxia Syndrome(FXTAS), Factor 5 Leiden, LCHAD, MCAD, Prothrombin (F2), Prader-Willi Syndrome
  
  
• Molecular Oncology Tests:
  BCL2, BCR/ABL1 qualitative, BCR/ABL1 quantitative (future test), Dyskeratosis congenita (DKC), FLT3, IGH, IGH Hypermutation, JAK2, Multiple Endocrine Neoplasia (MEN 2A and MEN 2B), PML/RARA, Soft Tissue Sarcoma testing, TRB, TRG
  
  
• Identity Testing:
  STR Pre-BMT testing, STR Post-BMT testing, STR Post Enriched Cell testing
  
  
• Pharmacogenetics:
  Thymidylate Synthase Enhancer Region (TYMS) for 5-fluoruracil response, Warfarin sensitivity (CYP2C9 and VKOR1) (future test), UGT1A1 for irinotecan sensitivity
  
  
• Specimen Requirements:
  Genetic request form , Oncology request form

For information about testing that is not listed here, please refer to the
AMP Test Directories or the GeneTests directory.